An In-Depth Case Study on Haematology Cell Counters
Hematology is the study of blood and the disorders related to it. Human blood is composed of ∼45% cellular components and ∼55% plasma. Blood has many functions, including transporting oxygen, regulating body temperature, and supporting the immune system.
Haematology cell counters or haematology analyzers are widely used for clinical and research applications. The haematology analyzers are used to count and study the characteristics of blood cells for diagnosing and monitoring the diseases. The haematology cell counters utilize three technologies, such as electrical impedance, flow cytometry, and fluorescent flow cytometry for analyzing blood cells. These technologies are used in different combinations of reagents and enzymes that assist in lysing blood cells to an extent from where it can be measured.
Download Sample PDF Copy
Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. The report also includes the profiles of key players in haematology cell counters market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Few companies engaged in the haematology cell counters
1. Sysmex
2. Abbott
3. Danaher Corporation (Beckman Coulter, Inc.)
4. Siemens AG (Siemens Healthcare GmbH)
5. Bio-Rad Laboratories, Inc.
6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7. Nihon Kohden Corporation
8. HORIBA, Ltd
9. F. Hoffmann-La Roche Ltd
10. Hycel Medical
Geographical Survey:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the haematology cell counters market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The haematology cell counters market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting haematology cell counters market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the haematology cell counters market in these regions.